| Amanda Lynn Sauer, CNM | |
|
2400 32nd Ave S, Fargo, ND 58103-5800 | |
| (701) 234-2000 | |
| Not Available |
| Full Name | Amanda Lynn Sauer |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 2400 32nd Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861122251 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (* (Not Available)) | Secondary |
| 367A00000X | Advanced Practice Midwife | R41517 (North Dakota) | Primary |
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.
Biomedical engineers Dr Marnie Winter and Professor Benjamin Thierry from UniSA's Future Industries Institute and the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology are part of a team of researchers who have isolated fetal cells from maternal blood using a tiny microfluidic device, allowing for improved genetic testing.
A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery hinges on a new understanding of the complex molecular chain reaction that occurs when the brain is exposed to too much ammonia.
Bariatric surgery may be an effective treatment for non-alcoholic fatty liver disease (NAFLD), suggests a new study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in the Journal of the Endocrine Society.
The Michael J. Fox Foundation for Parkinson's Research announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Lynn Sauer, CNM Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Amanda Lynn Sauer, CNM 2400 32nd Ave S, Fargo, ND 58103-5800 Ph: (701) 234-2000 |
News Archive
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.
Biomedical engineers Dr Marnie Winter and Professor Benjamin Thierry from UniSA's Future Industries Institute and the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology are part of a team of researchers who have isolated fetal cells from maternal blood using a tiny microfluidic device, allowing for improved genetic testing.
A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery hinges on a new understanding of the complex molecular chain reaction that occurs when the brain is exposed to too much ammonia.
Bariatric surgery may be an effective treatment for non-alcoholic fatty liver disease (NAFLD), suggests a new study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in the Journal of the Endocrine Society.
The Michael J. Fox Foundation for Parkinson's Research announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.
› Verified 5 days ago
Briana Powell, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2000 | |
Laurel A Mckeever, RN, MS, SNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 Fax: 701-417-2535 | |
Christa L Howell, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Jennifer L Janke, WHNP CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Terry J Burrell, CNM, PHD Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Denise C Powell, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Kelsey Leigh O'harris, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 301 Np Ave N, Fargo, ND 58102 Phone: 701-271-3344 |